HA
ACHN

Havens Advisors’s Achillion Pharmaceuticals ACHN Stock Holding History

Havens Advisors’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-281,000
Closed -$1.69M – 34
2019
Q4 		$1.69M Buy
+281,000
New +$1.63M 1.49% 20

Havens Advisors's ACHN Position: Q1 2020 in Review

Havens Advisors sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 281,000 shares — an estimated $1.69M sold.

Havens Advisors first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $1.69M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Havens Advisors reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Havens Advisors sold 281,000 Achillion Pharmaceuticals shares in Q1 2020, an estimated $1.69M.
  • Havens Advisors first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Havens Advisors's Achillion Pharmaceuticals position peaked at $1.69M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Havens Advisors's 13F filing for Q1 2020, filed 21 Apr 2020.